Neurological and psychiatric disorders in thyroid dysfunctions. The role of nuclear medicine: SPECT and PET imaging

Minerva Endocrinologica

Volumn 33, Issue 2, 2008, Pages 75-84

  Lass, P ^a   Slawek, J ^a   Derejko, M ^b   Rubello, D ^c  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

^b INSTITUTE OF PSYCHIATRY AND NEUROLOGY   (Poland)

^c VENETO INSTITUTE OF ONCOLOGY IOV IRCCS   (Italy)

Author keywords

Mental disorders; Nervous system diseases; Radionuclide imaging, positron emission tomography; Thyroid gland; Tomography, emission computed, single photon

Indexed keywords

RADIOISOTOPE;

APATHY; BRAIN BLOOD FLOW; CEREBROVASCULAR ACCIDENT; COGNITIVE DEFECT; DEMENTIA; DEPRESSION; HASHIMOTO DISEASE; HASHIMOTO ENCEPHALOPATHY; HORMONE SUBSTITUTION; HUMAN; HYPERTHYROIDISM; HYPOTHYROIDISM; MAJOR DEPRESSION; MENTAL DISEASE; METABOLISM; MOTOR PERFORMANCE; NEUROLOGIC DISEASE; NEUROTRANSMISSION; POSITRON EMISSION TOMOGRAPHY; REVIEW; RISK ASSESSMENT; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SPATIAL ORIENTATION; THYROID DISEASE; BRAIN DISEASE; CENTRAL NERVOUS SYSTEM DISEASE; METHODOLOGY; PSYCHOLOGICAL ASPECT; SCINTISCANNING; STROKE;

BRAIN DISEASES; CENTRAL NERVOUS SYSTEM DISEASES; COGNITION DISORDERS; DEMENTIA; DEPRESSION; HASHIMOTO DISEASE; HUMANS; HYPERTHYROIDISM; HYPOTHYROIDISM; MENTAL DISORDERS; POSITRON-EMISSION TOMOGRAPHY; STROKE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 49849093508     PISSN: 03911977     EISSN: 18271634     Source Type: Journal    
DOI: None     Document Type: Review

References (64)

1. Franklyn JA. Thyroid disease and its treatment: short- and long-term consequences. J R Coll Physicians Lond 1999;33:564-7.
2. Squizzato A, Gerdes VE, Brandjes DP, Büller HR, Stam J. Thyroid diseases and cerebrovascular disease. Stroke 2005;36:2302-10.
3. Porterfield SP, Hendrich CE. The role of thyroid hormones in prenatal and neonatal neurological development: current perspectives. Endocr Rev 1993;14:94-106.
4. Dugbartey AT. Neurocognitive aspects of hypothyroidism. Arch Intern Med 1998;158:1413-8.
5. Constant EL, de Volder AG, Ivanoiu A, Bol A, Labar A, Seghers A et al. Cerebral blood flow and glucose metabolism in hypothyroidism: a positron emission tomography study. J Clin Endocrinol Metabol 2001;86:3864-70. (Pubitemid 32755990)
6. Heinrich TW, Grahm G. Hypothyroidism presenting as psychosis: myxedema madness revisited. Clin Companion J Clin Psychiatry 2003;5:260-6.
7. Larisch R, Kley R, Nikolaus S, Sitte W, Franz M, Hautzel H et al. Depression and anxiety in different thyroid function states. Horm Metab Res 2004;36:650-3. (Pubitemid 39457644)
8. Balercia G, Boscaro M, Lombardo F, Carosa E, Lenzi A, Jannini EA. Sexual symptoms in endocrine diseases: psychosomatic perspectives. Psychoter Psychosom 2007;76:134-40. (Pubitemid 46582016)
9. Haggerty JJ Jr, Garbutt JC, Evans DL, Golden RN, Pedersen C, Simon JS et al. Subclinical hypothyroidism: a review of neuropsychiatric aspects. Int J Psychiatry Med 1990;20:193-208. (Pubitemid 20296013)
10. Finisterer J, Kuntscher D, Krugluger W. Pseudotumor cerebri from sinus venous thrombosis, associated with polycystic ovary syndrome and hereditary hypercoagulability. Gynecol Endocrinol 2007;23:179-82. (Pubitemid 46570218)
11. Ørstavik K, Norheim I, Jørum E. Pain and small-fiber neuropathy in patients with hypothyroidism. Neurology 2006;67:786-91.
12. Tonner DR, Schlechte JA. Neurologic complications of thyroid and parathyroid disease. Med Clin North Amer 1993;77:251-63.
13. Wiliams RS, Williams JP, Davis MR, Hutto RL. Primary hypothyroidism with pituitary hyperplasia and basal ganglia calcifications. Clin Imaging 1990;14:330-2.
14. Nicholas WC, Russell WF. Primary hypothyroidism presenting as a pituitary mass. J Miss State Med Assoc 2000;41:511-4.
15. Scheinberg P, Stead EAJ, Brannon ES, Warren JV. Correlative observation on cerebral metabolism and cardiac output in myxedema. J Clin Invest 1950;29:1139-46.
16. Sokoloff L, Wechsler RL, Mangold R, Balls K, Kety SS. Cerebral blood flow and oxygen consumption in hyperthyroidism before and after treatment. J Clin Invest 1953;32:202-8.
17. Nagamachi S, Jinnouchi S, Nishii R, Ishida Z, Fujita S, Futami S et al. Cerebral blood flow abnormalities induced by transient hypothyroidism after thyroidectomy - analysis by Tc-99m-HMPAO and SPM96. Ann Nucl Med 2004;18:469-77. (Pubitemid 39410245)
18. Krausz Y, Freedman N, Lester H, Newman JP, Barkai G, Bocher M et al. Regional cerebral blood flow in patients with mild hypothyroidism. J Nucl Med 2004;45:1712-5. (Pubitemid 47618480)
19. Guedj E, Taïeb D, De Laforte C, Ceccaldi M, Mundler O. Similitude of brain perfusion pattern in hypothyroidism and early Alzheimer's disease: physiopathologic considerations. J Nucl Med 2005;46;1247-8. (Pubitemid 43741088)
20. Marangell LB, Ketter TA, George MS, Pazzaglia PJ, Callahan AM, Callahan AM et al. Inverse relationship of peripheral thyrotropin-stimulating hormone levels to brain activity in mood disorders. Am J Psychiatry 1997;154:224-30.
21. Cordes J, Cano J, Haupt M. Reversible dementia in hypothyroidism. Nervenarzt 2000;71:588-90.
22. Davis JD, Tremont G. Neuropsychiatric aspects of hypothyroidism and treatment reversibility. Minerva Endocrinol 2007;32:49-65.
23. Davis JD, Stern RA, Flashman LA. Cognitive and neuropsychiatric aspects of subclinical hypothyroidism: significance in the elderly. Curr Psychiatr Rep 2003;5:384-90.
24. Bono G, Fancellu R, Blandini F, Santoro G, Mauri M. Cognitive and affective status in mild hypothyroidism and interactions with L-thyroxine treatment. Acta Neurol Scand 2004;110:59-66.
25. Kinuya S, Michigishi T, Tonami N, Aburano T, Tsuji S, Hashimoto T. Reversible cerebral hypoperfusion observed with Tc-99m HMPAO SPECT in reversible dementia caused by hypothyroidism. Clin Nucl Med 1999;24:666-8.
26. Constant EL, Adam S, Seron X, Bruyer R, Seghers A, Daumerie C. Hypothyroidism and major depression: a common executive dysfunction? J Clin Exp Neuropsychol 2006;28:790-807.
27. Bauer M, London ED, Rasgon N, Berman SM, Frye MA, Altshuler LL et al. Supraphysiological doses of levothyroxine alter regional cerebral metabolism and improve mood in bipolar depression. Molecular Psychiatry 2005;10:456-69.
28. Schraml FV, Beason-Held LL, Fletcher DW, Brown BP. Cerebral accumulation of Tc-99m ethyl cysteinate dimer (ECD) in severe, transient hypothyroidism. J Cereb Blood Flow Metabolism 2006;26:321-9.
29. Krausz Y, Freedman N, Lester H, Barkai G, Levin T, Bocher M et al. Brain SPECT study of common ground between hypothyroidism and depression. Int J Neuropsychopharmacol 2007;10:99-106.
30. Kaplan MM, Sarne DH, Schneider AB. In Search of the Impossible Dream? Thyroid hormone replacement therapy that treats all symptoms in all hypothyroid patients. J Clinical Endocrinol Metab 2003;88:4540-2.
31. Capet C, Jego A, Denis P, Noel P, Clerc I, Cornier AC et al. Is cognitive impairment related to hypothyroidism improved by hormone-replacement therapy? Rev Med Interne 2000;21:672-8.
32. Samuels MH, Schuff KG, Carlson NE, Carrello P, Janowsky JS. Health status, psychological symptoms, mood, and cognition in L-thyroxine-treated hypothyroid subjects. Thyroid 2007;17:249-58.
33. Joffe RT, Sawka AM, Marriott MJ, Macqueen GM, Hertzl C. Gernstein B. Does substitution of T4 with T3 Plus T4 for T4 replacement improve depressive symptoms in patients with hypothyroidism? Ann. N.Y. Acad Sci 2004;1032:287-8.
34. El-Kaissi S, Kotowicz MA, Berk M, Wall JR. Acute delirium in the setting of primary hypothyroidism: the role of thyroid hormone replacement therapy. Thyroid 2005;15:1099-101.
35. 31p magnetic-resonance spectroscopy. Lancet 1995;345:619-20.
36. Oatridge A, Bernard ML, Barnard ML, Puri BK, Taylor-Robinson SD, Hajnal JV et al. Changes in brain size with treatment in patients with hyper- or hypothyroidism. AJNR Am J Neuroradiol 2002;23:1539-44.
37. Madison L, Sensenbach W, Ochs L. Effect of hyperthyroidism and myxedema upon cerebral blood flow and metabolism. Am J Med 1951;11:246.
38. Sensenbach W, Madison L, Eisenberg S, Ochs L. The cerebral circulation and metabolism in hyperthyroidism and myxedema. J Clin Invest 1954;33:1434-40.
39. Chong JY Rowland LP, Utiger RD. Hashimoto encephalopathy: syndrome or myth? Arch Neurol 2003;60:164-71.
40. Mocellin R, Walterfang M, Velakoulis D. Hashimoto's encephalopathy: epidemiology, pathogenesis and management. CNS Drugs 2007;21:799-811.
41. Sawka AM, Fatourechi V, Boeve BF, Mokri B. Rarity of encephalopathy associated with autoimmune thyroiditis: a case series from Mayo Clinic from 1950 to 1996. Thyroid 2003;13:227-8.
42. Fatourechi V. Hashimoto's encephalopathy: myth or reality? An endocrinologist's perspective. Best Practice Pract Res Clin Endocrinol Metab 2005;19:53-66.
43. Hatano Y, Mori H, Kakusaka K, Kitara T, Urale T, Mizuno Y. A patient with Hashimoto's encephalopathy showing subacute global cognitive dysfunction. Rinsho Shinkeigaku 2003;43:360-2.
44. Jamrozik Z, Janik P, Kwiecinski H. Hashimoto's encephalopathy. Case report and literature review. Neurol Neurochir Pol 2004;38:55-9.
45. Shibata N, Yamamoto Y, Sunami N, Suga M, Yamashita Y. Isolated angiitis of the CNS associated with Hashimoto's disease. Rinsho Shinkeigaku 1992;32:191-8.
46. Okamoto K, Mori C, Kamogawa K, Tominaga K, Okuda B. Case of Hashimoto's encephalopathy with diffuse white matter lesions on diffusion-weighted MRI. Rinsho Shinkeigaku 2007;47:112-5.
47. Kaya M, Cermik TF, Bedel D, Kutucu Y, Yigitbasi ON. Assessment of alterations in regional cerebral blood flow in patients with hypothyroidism due to Hashimoto's thyroiditis. J Endocrinol Invest 2007;30:491-6.
48. Forchetti CM, Katsamakis G, Garron DC. Autoimmune thyroiditis and a rapidly progressive dementia: global hypoperfusion on SPECT scanning suggests a possible mechanism. Neurology 1997;49:623-6.
49. Chen PL, Wang PY, Hsu HY. Reversible electroencephalographic and single photon emission computed tomography abnormalities in Hashimoto's encephalopathy. J Chin Med Assoc 2005;68:77-81.
50. Piga M, Serra A, Deiana L, Loi GL, Satta L, Di Liberto M et al. Brain perfusion abnormalities in patients with euthyroid autoimmune thyroiditis. Eur J Nucl Med Mol Imaging 2004;31:1639-44.
51. Zettinig G, Asenbaum S, Fueger BJ, Hofmann A, Diemling M, Mittlbeck M et al. Increased prevalence of sublinical brain perfusion abnormalities in patients with autoimmune thyroiditis: evidence of Hashimoto's encephalitis? Clin Endocrinol (Oxf) 2003;59:637-43.
52. Maes J, Michotte A, Velkeniers B, Stadnik T, Jochmans K. Hyperthyroidism with increased factor VIII procoagulant protein as a predisposing factor for cerebral venous thrombosis. J Neurol Neurosurg Psychiatr 2002;73:458.
53. Mouton S, Nighoghossian N, Berruyer M, Philippeau F, Cakmak S, Honnorat J et al. Hyperthyroidism and cerebral venous thrombosis. Eur Neurol 2005;54:78-80.
54. Vogel A, Elberling TV, Hording M, Dock J, Rasmussen AK, Feldt-Rasmussen AK et al. Affective symptoms and cognitive functions in the acute phase of Graves' thyrotoxicosis. Psychoneuroendocrinology 2007;32:36-43.
55. Trzepacz PT, McCue M, Klein I, Levey GS, Greenhouse J. A psychiatric and neuropsychological study of patients with untreated Graves' disease. Gen Hosp Psychiatry 1988;10:49-55.
56. Bunevicius R, Velickiene D, Prange AJ Jr. Mood and anxiety disorders in women with treated hyperthyroidism and ophthalmopathy caused by Graves' disease. Gen Hosp Psychiatry 2005;27:133-9.
57. Eaton WW, Byrne M, Ewald H, Mors O, Chen CY, Agerbo E et al. Association of schizophrenia and autoimmune diseases: linkage of Danish national registers. Am J Psychiatry 2006;163:521-8.
58. Brenner I. Apathetic hyperthroidism. J Clin Psychiatry 1978;39:479-80.
59. Lichtstein DM, Arteaga RB. Rhabdomyolysis associated with hyperthyroidism. Am J Med Sci 2006;332:103-5.
60. Kung AW. Neuromuscular complications of thyrotoxicosis. Clin Endocrinol (Oxf) 2007;67:645-50.
61. Schreckenberger MF, Egle UT, Drecker S, Buchholz HG, Weber MM, Bartenstein P et al. Positron emission tomography reveals correlations between brain metabolism and mood changes in hyperthyroidism. J Clin Endocrinol Metab 2006;91:4786-91.
62. Döbert N, Hamscho N, Menzel C, Peters J, Frölich L, Tsolakis A et al. Subclinical hyperthyroidism in dementia and correlation of the metabolic index in FDG-PET. Acta Med Austriaca 2003;30:130-43. (Pubitemid 38043944)
63. Fukui T, Hasegawa Y, Takenaka H. Hyperthyroid dementia: clinicoradiological findings and response to treatment. J Neurol Sci 2001;184:81-8. (Pubitemid 32166730)
64. Seo SW, Lee BI, Lee JD, Park SA, Kim KS, Kim SH et al. Thyrotoxic autoimmune encephalopathy: a repeat positron emission tomography study. J Neurol Neurosurg Psychiatr 2003;74:504-6.